Kwality Pharmaceuticals Ltd.

BSE: 539997

Mid-range Performer

Download real time

814.75 -4.05 (-0.49%)

84.33% Gain from 52W Low

7,496 BSE Volume

BSE 16 Apr, 2025 3:31 PM (IST)

845.4

Market Cap

Above industry Median

0.9

Beta 1Year

Low volatility

Kwality Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Kwality Pharmaceuticals Ltd. on BSE

Search Inside the pdf :

Kwality Pharmaceuticals Ltd.

09 Apr 2025

814.75

-0.49%

Company Update

Kwality Pharmaceuticals Ltd - 539997 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for quarter ended 31-03-2025.

Kwality Pharmaceuticals Ltd.

26 Mar 2025

814.75

-0.49%

SAST

Kwality Pharmaceuticals Ltd - 539997 - Closure of Trading Window

BSE India

Closure of Trading Window.

Kwality Pharmaceuticals Ltd.

14 Feb 2025

814.75

-0.49%

Company Update

Kwality Pharmaceuticals Ltd - 539997 - Kwality Pharmaceutical Limited Receives Product Registration Of Cyclophosphamide 1Gm In …

BSE India

Kwality Pharmaceuticals Limited receives product registrartion of Cyclophosphamide 1gm in Mexico

Kwality Pharmaceuticals Ltd.

04 Feb 2025

814.75

-0.49%

Company Update

Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

NEWSPAPER PUBLICATION OF RESULTS FOR Q.E. 31-12-2024

Kwality Pharmaceuticals Ltd.

31 Jan 2025

814.75

-0.49%

Corp. Note

Kwality Pharmaceuticals Ltd - 539997 - Integrated Filing (Financial)

BSE India

Integrated filing (Financial) for the quarter and nine months ended December 31,2024 is enclosed

Kwality Pharmaceuticals Ltd.

31 Jan 2025

814.75

-0.49%

Result

Kwality Pharmaceuticals Ltd - 539997 - UNAUDITED FINANCIAL RESULTS FOR Q.E. 31-12-2024

BSE India

UNAUDITED FINANCIAL RESULTS FOR Q.E. 31-12-2024

Kwality Pharmaceuticals Ltd.

31 Jan 2025

814.75

-0.49%

Board Meeting

Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Outcome for SUBMISSION OF UNAUDITED FINANCIAL RESULTS FOR …

BSE India

Pursuant to Regulation 30 & 33 read with clause 4 (h) of Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulation, 2015 ('Listing Regulations'), this is to inform your that Board of Directors in its meeting held today i.e., January 31, 2025, have inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024, along with Limited Review Report issued by Statutory Auditors of the Company. A copy of the same is enclosed herewith.

Kwality Pharmaceuticals Ltd.

21 Jan 2025

814.75

-0.49%

Company Update

Kwality Pharmaceuticals Ltd - 539997 - KWALITY PHARMA RECEIVED SFDA APPROVAL FOR ITS GENERAL INJECTABLES AND …

BSE India

KWALITY PHARMA RECEIVED SFDA APPROVAL FOR ITS GENERAL INJECTABLES AND BETA LACTAM (UNIT 1 & 2 IN AMRITSAR).

Kwality Pharmaceuticals Ltd.

20 Jan 2025

814.75

-0.49%

Board Meeting

Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Intimation for Declaring Standalone And Consolidated Unaudited Financial …

BSE India

Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results for the Quarter and Nine months ended December 31, 2024 along with Limited Review Report.

Kwality Pharmaceuticals Ltd.

12 Jan 2025

814.75

-0.49%

Company Update

Kwality Pharmaceuticals Ltd - 539997 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

CERTIFICATE UNDER REG 74(5) FOR Q.E. 31-12-2024 IS ENCLOSED

Is Kwality Pharmaceuticals Ltd. worth buying?

56 Votes:

Buy 71.43%

Sell 16.07%

Hold 12.5%